E2 - Endovascular Engineering Email Format
Medical Equipment ManufacturingCalifornia, United States11-50 Employees
Endovascular Engineering, Inc. develops endovascular devices for removing clots in the venous system, targeting venous thromboembolism. The company is based in Menlo Park, California, and operates within the medical equipment manufacturing sector. Its work centers on endovascular approaches to clot removal for patients with venous thromboembolism. Its customers are healthcare providers and hospitals that treat venous thromboembolism, seeking better clot removal options. The company has progressed its Hēlo Thrombectomy System through the ENGULF Study, which reported positive initial results. In 2024, the company announced the appointment of Dan Rose as Chief Executive Officer.